NGL Fine Chem Ltd (NGLFINE) is currently trading at 2,805.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

NGL Fine-Chem is a vertically integrated pharmaceutical manufacturer focused primarily on veterinary active pharmaceutical ingredients (APIs), producing 45 APIs (43 veterinary, 2 human), one intermediate and 11 finished dosage forms across five manufacturing facilities with WHO‑GMP and multiple ISO accreditations. Q1FY27 reported revenue of ₹139.16 crore, up 33.6% year-on-year, with EBITDA rising to ₹23.29 crore and margins expanding to 16.73%; management notes margin improvement was partly driven by inventory gains from rising prices and a one‑off reversal of forex provisions that aided quarterly profitability. Phase II greenfield expansion at Tarapur is essentially complete on capex outlay and is slated for commissioning in H2FY27; management expects commercial production in H2FY27 and highlights that the project scope and total cost remain unchanged, intended to support medium‑term growth and new product launches. The business is highly concentrated toward animal health, with animal APIs representing 95% of Q1FY27 revenue and market share in key products ranging from 15% to over 50%; customer and product concentration remains elevated, with top five products at 48% and top five customers at 26% in the latest quarter. Working capital and balance sheet movements reflect capex-led scaling: FY26 net block rose and long‑term borrowings increased to ₹56.40 crore, while inventories and trade receivables expanded, indicating higher throughput but also elevated liquidity needs as capacity ramps and new commercial volumes phase in.

Over the past 52 weeks, NGL Fine Chem Ltd has traded between a low of ₹1,261.00 and a high of ₹3,595.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

NGL Fine Chem Ltd has a market capitalization of approximately 1,771.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

NGL Fine Chem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.97 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,771.65 Cr, NGL Fine Chem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

NGL Fine Chem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of NGL Fine Chem Ltd is 30.97. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

NGL Fine Chem reported consolidated profit after tax of Rs 16.25 crore for the quarter ended September 30, 2026. This was Rs 9.63 crore in the corresponding 2025 quarter and Rs 18.40 crore in the June 2026 quarter.

NGL Fine Chem has disclosed two captive projects with 6.70 MW of stated capacity in total. The solar project is 3.10 MWp and the wind allocation is 3.60 MW, although the two technologies are reported using different capacity measures.

NGL Fine-Chem generated Rs 57.6703 crore of operating profit before working-capital changes in the half year ended September 30, 2026. Inventory growth of Rs 48.1048 crore and receivables growth of Rs 5.8832 crore absorbed cash, although increases in trade payables and other liabilities partly offset those uses. After Rs 11.4288 crore of tax payments, net operating cash flow was Rs 35.7952 crore.

NGL Fine-Chem Ltd’s Board is scheduled to consider and approve unaudited Q2 and H1 FY27 results on November 6, 2026. The results cover the quarter and half year ended September 30, 2026.